Dr. David Brian Karpf, MD

Dr. Karpf practices at Stanford Hospital at 300 Pasteur Drive in Stanford, California, part of Stanford University.

Dr. Karpf's NPI, 1306913744, was assigned on November 29, 2006. Dr. Karpf graduated from UC San Diego School of Medicine in 1980. Dr. Karpf holds California license G45513.

Dr. Karpf's primary practice is Stanford Hospital at 300 Pasteur Drive, at 300 Pasteur Drive, Stanford, CA 94305 in Santa Clara County. The practice phone is (650) 723-4000.

Dr. Karpf's primary practice is Stanford Hospital at 300 Pasteur Drive in Stanford, California, part of Stanford University. The medical group on file is Stanford Health Care. Dmand AI also links Dr. Karpf to 1 more hospital, named with a free account. Dr. Karpf's employer is on file too: a hospital.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Karpf practices, 2 sites in all. Vendor and product names are available with a free account.

Endocrinology, diabetes and metabolism is Dr. Karpf's primary specialty in the NPI Registry, under taxonomy code 207RE0101X. Dr. Karpf is board certified in internal medicine by the American Board of Internal Medicine. Dmand AI has Dr. Karpf's licenses on file in 2 states: California and New Jersey.

Dmand AI lists osteoporosis among the conditions Dr. Karpf treats.

CMS data shows 14 Medicare services from Dr. Karpf across 1 procedure code in 2021, all of them office visits. Medicare paid $1,597 for them. Every service was in a facility, such as a hospital, rather than an office.

Across all payers, Dmand AI patient panel data puts Dr. Karpf's median patient age at 65, with 83% women.

In 2024, Dr. Karpf wrote 48 Medicare Part D claims for 13 patients. 81% of them were for generic drugs. CMS names the drug for 18 of them, across 1 drug with 11 or more claims each, at $169 in total drug cost. In 2023, CMS named 35 claims across 2 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 89 out of 100 for Dr. Karpf for performance year 2024, reported as part of a group. CMS lists Dr. Karpf as offering telehealth.

Dmand AI links 22 papers to Dr. Karpf, published from 2011 to 2020. The most frequent topics are Alendronate, Double-Blind Method and Osteoporosis, Postmenopausal. Dr. Karpf has published most often in J Bone Miner Res. Dr. Karpf's most frequent co-authors are Douglas C. Bauer, MD, Theodore Leslie Deweese, MD and Boris Kerzner, MD.

Dmand AI links Dr. Karpf to 4 clinical trials, 3 of them phase 3 studies. Conditions studied include Failure to Thrive, Dwarfism, Pituitary and Hypoparathyroidism. Ascendis Pharma A/S sponsors the most, 2.

CMS Open Payments shows 11 general payments to Dr. Karpf from 5 drug and device companies from 2016 to 2024. Food and beverage make up the largest share, 42% of the total. Alexion Pharmaceuticals, Inc. paid the most, $845.

Dmand AI lists 10 awards for Dr. Karpf, most recently Fellow in 2020.

Dr. Karpf graduated from UC San Diego School of Medicine in 1980. Dr. Karpf is a member of ENDO.

Dr. Karpf is in network with 5 carriers, including Blue Cross Blue Shield of Michigan, Blue Cross Blue Shield of Massachusetts and HCSC. Medicare plans come from the most carriers, 5. Check the plan with the practice before a visit.